Tci Wealth Advisors, Inc. Nektar Therapeutics Transaction History

Tci Wealth Advisors, Inc.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$2.03 - $4.28 $1,881 - $3,967	927 Added 290.6%	1,246 $2,000
Q3 2022 Nov 08, 2022	SELL	$3.04 - $5.14 $580 - $981	-191 Reduced 37.45%	319 $1,000
Q2 2022 Jul 19, 2022	BUY	$3.17 - $6.17 $1,616 - $3,146	510 New	510 $2,000
Q1 2022 Apr 29, 2022	SELL	$4.16 - $13.72 $2,458 - $8,108	-591 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$10.83 - $18.41 $6,118 - $10,401	565 Added 2173.08%	591 $8,000
Q3 2021 Oct 29, 2021	SELL	$13.07 - $18.84 $2,169 - $3,127	-166 Reduced 86.46%	26 $0
Q2 2021 Aug 02, 2021	BUY	$16.52 - $20.4 $2,742 - $3,386	166 Added 638.46%	192 $3,000
Q4 2020 Jan 21, 2021	SELL	$15.77 - $19.03 $4,336 - $5,233	-275 Reduced 91.36%	26 $0
Q2 2020 Jul 20, 2020	BUY	$16.86 - $23.44 $2,326 - $3,234	138 Added 84.66%	301 $7,000
Q1 2020 Apr 14, 2020	SELL	$14.47 - $27.96 $940 - $1,817	-65 Reduced 28.51%	163 $3,000
Q3 2019 Oct 17, 2019	SELL	$16.91 - $36.27 $794 - $1,704	-47 Reduced 17.09%	228 $4,000
Q2 2019 Jul 23, 2019	BUY	$31.0 - $36.3 $1,023 - $1,197	33 Added 13.64%	275 $10,000
Q1 2019 Apr 11, 2019	BUY	$31.58 - $46.35 $410 - $602	13 Added 5.68%	242 $8,000
Q4 2018 Jan 17, 2019	BUY	$30.43 - $56.65 $395 - $736	13 Added 6.02%	229 $8,000
Q3 2018 Nov 02, 2018	BUY	$46.46 - $68.49 $1,115 - $1,643	24 Added 12.5%	216 $13,000
Q2 2017 Aug 10, 2017	BUY	N/A	192	192 $4,000

145

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.